Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki et al. · The Lancet · 1984 · 1.3K citations · Full text

Veterinary Medicine, Immunology, Pathology +6

Malignant lymphomas in transplantation patients.

Israel Penn, William A. Hammond, L Brettschneider et al. · PubMed · 1969 · 467 citations · Full text

Medicine, Immunology, Oncology +14

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

Sylvain Choquet · Blood · 2005 · 425 citations · Full text

Life Sciences, Hematology, Immunology +12

REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1

Donald E. Tsai, Christine Hardy, John E. Tomaszewski et al. · Transplantation · 2001 · 364 citations

Medicine, Immunology, Surgery +16

Treatment of PTLD with Rituximab or Chemotherapy

Rebecca Elstrom, C. Andreadis, Nicole A. Aqui et al. · American Journal of Transplantation · 2006 · 260 citations · Full text

Medicine, Immunology, Oncology +13